A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
NCT00109135
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Smoking
Interventions
DRUG:
taranabant
Sponsor
Merck Sharp & Dohme LLC